Researchers at Osaka Metropolitan University (OMU), in partnership with K.K. DNAFORM and the National Institute for Biomedical Research (INRB) in the Democratic Republic of the Congo, are developing a portable, rapid diagnostic system to detect the Bundibugyo virus (BDBV). The project, supported by the Global Health Innovative Technology Fund (GHIT Fund), aims to provide field-ready, … Read more
Tuberculosis claimed 1.23 million lives in 2024, remaining one of the world’s deadliest infectious diseases due to the bacterium’s highly selective outer shell, the mycomembrane. Researchers at the University of Massachusetts Amherst have now developed a paired screening and machine-learning approach to identify which drug compounds can successfully penetrate this barrier, according to findings published … Read more
Researchers at the University of Massachusetts Amherst have developed an artificial intelligence model called MycoPermeNet to accelerate the discovery of tuberculosis drugs. By combining this AI with a high-throughput screening technique known as PAC-MAN, the team can predict which chemical compounds can penetrate the bacterium’s unique mycomembrane, potentially speeding up the search for effective treatments … Read more
The Bacillus Calmette-Guérin (BCG) vaccine, typically used to prevent tuberculosis, may remodel the brain’s immune environment to potentially lower Alzheimer’s disease risk, according to research published in Communications Medicine. A year-long study led by Mass General Brigham investigators found the vaccine increased immune cell responsiveness and altered Alzheimer’s-related biomarkers in older adults without pre-existing pathology. … Read more
Hyperpigmentation as a Clinical Red Flag Unexplained skin darkening on the hands, feet, gums, and tongue can serve as the primary diagnostic indicator of Addison’s disease, a rare endocrine disorder. According to a case report published in the journal Skin on June 4, 2026, clinicians identified this specific hyperpigmentation in a 24-year-old patient two years … Read more
India is transitioning its national tuberculosis strategy from basic disease control to total elimination through the National Tuberculosis Elimination Program (NTEP). According to a review published in the journal Zoonoses, this shift addresses longstanding barriers including drug-resistant TB, HIV co-infection, and fragmented private sector regulation that have historically hindered mortality reduction efforts. How has India’s … Read more
New Frontiers in Diagnosing Latent Tuberculosis Infection Diagnosing latent tuberculosis infection (LTBI) has long been a clinical challenge, primarily because there is no single gold-standard test available to practitioners. Recent research published in BIO Integration suggests that the future of TB diagnostics may lie in the field of metabolomics—the study of chemical processes involving metabolites. … Read more
The Trillion-Dollar Drain: Why TB is Now a Global Economic Crisis For decades, the conversation surrounding tuberculosis (TB) has been confined to the halls of clinics and public health departments. It has been framed as a medical battle—a fight against a persistent bacterium and a struggle for human survival. However, a paradigm shift is occurring. … Read more
The Shift Toward Precision Public Health Surveillance The recent large-scale screenings in Bedok highlight a critical evolution in how modern cities manage infectious diseases. We are moving away from broad, generalized health checks toward “precision surveillance”—the ability to identify and isolate transmission clusters in real-time. By focusing on specific high-traffic hubs—such as community centers, hawker … Read more
Turning Routine Screening Into a Window for Longevity For decades, the medical community has understood that the immune system is a primary driver of the aging process. As we grow older, we often see a decline in vaccination efficacy, an increase in infection risks and rising levels of systemic inflammation. However, the challenge has always … Read more